OXAZOLYL-ARYLOXYACETIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS
Compounds represented by the following structural formula (I), and pharmaceutically acceptable salts, solvates and hydrates thereof, wherein R1 is an unsubstituted or substituted aryl, heteroaryl, cycloalkyl, aryl-alkyl, heteroaryl-alkyl or cycloalkyl-alkyl, R2 is H, alkyl or haloalkyl, the polymeth...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BROOKS DAWN ALISA DOMINIANNI SAMUEL JAMES WINNEROSKI LEONARD LARRY GODFREY ALEXANDER GLENN ZHU GUOXIN CONNER SCOTT EUGENE WARSHAWSKY ALAN M RITO CHRISTOPHER JOHN GOSSETT LYNN STACY TRIPP ALLIE EDWARD |
| description | Compounds represented by the following structural formula (I), and pharmaceutically acceptable salts, solvates and hydrates thereof, wherein R1 is an unsubstituted or substituted aryl, heteroaryl, cycloalkyl, aryl-alkyl, heteroaryl-alkyl or cycloalkyl-alkyl, R2 is H, alkyl or haloalkyl, the polymethylene chain (II), is saturated or may contain a carbon-carbon double bond, while n is 2, 3, 4, W is O or S, Y is an unsubstituted or substituted phenylene, naphthylene or 1, 2, 3, 4 tetrahydronaphthylene, R3 is H, alkyl or haloalkyl, R4 is H, alkyl, haloalkyl or a substituted or unsubstituted benzyl, are useful for modulating a preoxisome proliferator activated receptor, particularly in the treatment of diabetes mellitus. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2008146631A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2008146631A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2008146631A13</originalsourceid><addsrcrecordid>eNrjZHDzj3CM8veJ9NF1DIr08Y-IdHR2DfF0VnB09nRRcHEN8gxzDPEMcw1WcPRzUQjxcPUMUggNdlVwDFYICHAMUnB09_fzDA4J5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgYGFoYmZmbGho6GxsSpAgCGOi1x</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>OXAZOLYL-ARYLOXYACETIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS</title><source>esp@cenet</source><creator>BROOKS DAWN ALISA ; DOMINIANNI SAMUEL JAMES ; WINNEROSKI LEONARD LARRY ; GODFREY ALEXANDER GLENN ; ZHU GUOXIN ; CONNER SCOTT EUGENE ; WARSHAWSKY ALAN M ; RITO CHRISTOPHER JOHN ; GOSSETT LYNN STACY ; TRIPP ALLIE EDWARD</creator><creatorcontrib>BROOKS DAWN ALISA ; DOMINIANNI SAMUEL JAMES ; WINNEROSKI LEONARD LARRY ; GODFREY ALEXANDER GLENN ; ZHU GUOXIN ; CONNER SCOTT EUGENE ; WARSHAWSKY ALAN M ; RITO CHRISTOPHER JOHN ; GOSSETT LYNN STACY ; TRIPP ALLIE EDWARD</creatorcontrib><description>Compounds represented by the following structural formula (I), and pharmaceutically acceptable salts, solvates and hydrates thereof, wherein R1 is an unsubstituted or substituted aryl, heteroaryl, cycloalkyl, aryl-alkyl, heteroaryl-alkyl or cycloalkyl-alkyl, R2 is H, alkyl or haloalkyl, the polymethylene chain (II), is saturated or may contain a carbon-carbon double bond, while n is 2, 3, 4, W is O or S, Y is an unsubstituted or substituted phenylene, naphthylene or 1, 2, 3, 4 tetrahydronaphthylene, R3 is H, alkyl or haloalkyl, R4 is H, alkyl, haloalkyl or a substituted or unsubstituted benzyl, are useful for modulating a preoxisome proliferator activated receptor, particularly in the treatment of diabetes mellitus.</description><language>eng</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080619&DB=EPODOC&CC=US&NR=2008146631A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080619&DB=EPODOC&CC=US&NR=2008146631A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BROOKS DAWN ALISA</creatorcontrib><creatorcontrib>DOMINIANNI SAMUEL JAMES</creatorcontrib><creatorcontrib>WINNEROSKI LEONARD LARRY</creatorcontrib><creatorcontrib>GODFREY ALEXANDER GLENN</creatorcontrib><creatorcontrib>ZHU GUOXIN</creatorcontrib><creatorcontrib>CONNER SCOTT EUGENE</creatorcontrib><creatorcontrib>WARSHAWSKY ALAN M</creatorcontrib><creatorcontrib>RITO CHRISTOPHER JOHN</creatorcontrib><creatorcontrib>GOSSETT LYNN STACY</creatorcontrib><creatorcontrib>TRIPP ALLIE EDWARD</creatorcontrib><title>OXAZOLYL-ARYLOXYACETIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS</title><description>Compounds represented by the following structural formula (I), and pharmaceutically acceptable salts, solvates and hydrates thereof, wherein R1 is an unsubstituted or substituted aryl, heteroaryl, cycloalkyl, aryl-alkyl, heteroaryl-alkyl or cycloalkyl-alkyl, R2 is H, alkyl or haloalkyl, the polymethylene chain (II), is saturated or may contain a carbon-carbon double bond, while n is 2, 3, 4, W is O or S, Y is an unsubstituted or substituted phenylene, naphthylene or 1, 2, 3, 4 tetrahydronaphthylene, R3 is H, alkyl or haloalkyl, R4 is H, alkyl, haloalkyl or a substituted or unsubstituted benzyl, are useful for modulating a preoxisome proliferator activated receptor, particularly in the treatment of diabetes mellitus.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHDzj3CM8veJ9NF1DIr08Y-IdHR2DfF0VnB09nRRcHEN8gxzDPEMcw1WcPRzUQjxcPUMUggNdlVwDFYICHAMUnB09_fzDA4J5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgYGFoYmZmbGho6GxsSpAgCGOi1x</recordid><startdate>20080619</startdate><enddate>20080619</enddate><creator>BROOKS DAWN ALISA</creator><creator>DOMINIANNI SAMUEL JAMES</creator><creator>WINNEROSKI LEONARD LARRY</creator><creator>GODFREY ALEXANDER GLENN</creator><creator>ZHU GUOXIN</creator><creator>CONNER SCOTT EUGENE</creator><creator>WARSHAWSKY ALAN M</creator><creator>RITO CHRISTOPHER JOHN</creator><creator>GOSSETT LYNN STACY</creator><creator>TRIPP ALLIE EDWARD</creator><scope>EVB</scope></search><sort><creationdate>20080619</creationdate><title>OXAZOLYL-ARYLOXYACETIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS</title><author>BROOKS DAWN ALISA ; DOMINIANNI SAMUEL JAMES ; WINNEROSKI LEONARD LARRY ; GODFREY ALEXANDER GLENN ; ZHU GUOXIN ; CONNER SCOTT EUGENE ; WARSHAWSKY ALAN M ; RITO CHRISTOPHER JOHN ; GOSSETT LYNN STACY ; TRIPP ALLIE EDWARD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2008146631A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2008</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BROOKS DAWN ALISA</creatorcontrib><creatorcontrib>DOMINIANNI SAMUEL JAMES</creatorcontrib><creatorcontrib>WINNEROSKI LEONARD LARRY</creatorcontrib><creatorcontrib>GODFREY ALEXANDER GLENN</creatorcontrib><creatorcontrib>ZHU GUOXIN</creatorcontrib><creatorcontrib>CONNER SCOTT EUGENE</creatorcontrib><creatorcontrib>WARSHAWSKY ALAN M</creatorcontrib><creatorcontrib>RITO CHRISTOPHER JOHN</creatorcontrib><creatorcontrib>GOSSETT LYNN STACY</creatorcontrib><creatorcontrib>TRIPP ALLIE EDWARD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BROOKS DAWN ALISA</au><au>DOMINIANNI SAMUEL JAMES</au><au>WINNEROSKI LEONARD LARRY</au><au>GODFREY ALEXANDER GLENN</au><au>ZHU GUOXIN</au><au>CONNER SCOTT EUGENE</au><au>WARSHAWSKY ALAN M</au><au>RITO CHRISTOPHER JOHN</au><au>GOSSETT LYNN STACY</au><au>TRIPP ALLIE EDWARD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>OXAZOLYL-ARYLOXYACETIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS</title><date>2008-06-19</date><risdate>2008</risdate><abstract>Compounds represented by the following structural formula (I), and pharmaceutically acceptable salts, solvates and hydrates thereof, wherein R1 is an unsubstituted or substituted aryl, heteroaryl, cycloalkyl, aryl-alkyl, heteroaryl-alkyl or cycloalkyl-alkyl, R2 is H, alkyl or haloalkyl, the polymethylene chain (II), is saturated or may contain a carbon-carbon double bond, while n is 2, 3, 4, W is O or S, Y is an unsubstituted or substituted phenylene, naphthylene or 1, 2, 3, 4 tetrahydronaphthylene, R3 is H, alkyl or haloalkyl, R4 is H, alkyl, haloalkyl or a substituted or unsubstituted benzyl, are useful for modulating a preoxisome proliferator activated receptor, particularly in the treatment of diabetes mellitus.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2008146631A1 |
| source | esp@cenet |
| subjects | ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | OXAZOLYL-ARYLOXYACETIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T19%3A59%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BROOKS%20DAWN%20ALISA&rft.date=2008-06-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2008146631A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |